Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2016 / Cilt: 26 - Sayı: 3

Prostat kanseri Radyoterapisi Sırasında Fraksiyonlar Arası Seminal Vezikül Hareketleri ve Doz Değişimlerinin IGRT ile Değerlendirilmesi

Evaluation of Interfractional Movement of the Seminal Vesicle and Dose Variations with IGRT Throughout the Prostate Cancer Radiotherapy

Pages
129–135
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although it seems that there is a need to give larger margin to the SV in posterior direction, the actual cumulative doses delivered to SV throughout the treatment were within the prescribed dose.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To validate the actual cumulative doses delivered to the seminal vesicle (SV) depending on the organ movement using kV-Cone Beam CT (kV-CBCT) datasets acquired during prostate image-guided radiation therapy.
📊
Key Findings & Data:Both the prostate and the first 2 cm of the SV were included in the CTV.
💡
Conclusion & Impact:Although it seems that there is a need to give larger margin to the SV in posterior direction, the actual cumulative doses delivered to SV throughout the treatment were within the prescribed dose.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

To validate the actual cumulative doses delivered to the seminal vesicle (SV) depending on the organ movement using kV-Cone Beam CT (kV-CBCT) datasets acquired during prostate image-guided radiation therapy. Ten patients with intermediate risk prostate cancer treated with IMRT were included in this study. Both the prostate and the first 2 cm of the SV were included in the CTV. PTV margin was 8 mm in all directions except posterior, where it was 5 mm. Sixteen kV-CBCT scans per patient were used for assessments. After each kV-CBCT was matched with the planning CT based on prostate, the SV were recontoured as proximal, distal SV and both of them together (the whole SV). Actual delivered doses to the SV were assessed by means of DVH. The variations in certain dosevolume parameters were analyzed using the Student's test. Systematic and random errors of the SV and margins were assessed using the van-Herk formula. We observed that the SV movement in the anterior-posterior direction was significantly more compared to superior-inferior and left-right direction. The dose volume variations for the whole SV (D98%, D50%, D2%) and the distal SV (D98%, D95%, D50%) were significantly different than the planned doses. However, both the whole SV and the distal SV received the prescribed dose. Although it seems that there is a need to give larger margin to the SV in posterior direction, the actual cumulative doses delivered to SV throughout the treatment were within the prescribed dose.

Özet

Bu çalışmanın amacı, kV-Cone Beam CT (kV-CBCT) ile görüntü kılavuzluğunda prostat kanseri radyoterapisinde organ hareketine bağlı olarak seminal veziküllerin aldığı kümülatif dozların doğruluğunun değerlendirilmesidir. Çalışmamıza IMRT tekniği ile tedavi edilmiş orta risk prostat kanserli on hasta dahil edilmiştir. Prostat ve seminal vesiküllerin ilk 2 cm'lik bölümü CTV'ye dahil edilmiştir. Prostat ve SV'e posterior yönden 5 mm, diğer yönlerden 8 mm PTV marjı verilmiştir. Her hastadan 16 kV-CBCTalınmış ve SV'ye verilen marjın yeterli olup olmadığını saptamak için seçilen kV-CBCT görüntüleri ile planlama BT görüntüleri prostat referans alınarak offline eşleştirilmiştir. Seminal veziküller, proksimal-distal SV şeklinde ayrı ayrı ve her ikisi birlikte tüm SV olacak şekilde yeniden konturlanmıştır. Seminal veziküllerin aldığı doz DVH yardımı ile değerlendirilmiştir. Doz volüm histogramındaki değişiklikler Student test ile analiz edilmiştir. Sistematik ve random hatalar van-Herk formülü ile değerlendirilerek gerekli emniyet marjları bulunmuştur. Seminal vezikül hareketinin alt-üst ve sağ-sol yöne kıyasla ön-arka eksende daha fazla olduğu görülmüştür. Tüm SV için (D98% D50,% D2%) ve distal SV için doz volüm değişiklikleri (D98% D95,% D50%) planlanan dozlardan önemli ölçüde farklı bulunmuştur. Bununla birlikte, tüm SV ve distal SV'in tanımlanan dozu aldığı tespit edilmiştir. Çalışmamıza göre PTV marjının posterior yönde daha fazla olması gerektiği görülmesine rağmen, tedavi boyunca verilen dozlara kümülatif olarak bakıldığında SV'ler tanımlanan dozu aldığı için posterior marjin değerlerinde herhangi bir değişikliğe gidilmemiştir.

🔖

Cite This Article

ERGEN, S. A., OKSUZ, D. C., IKTUEREN, B., CAVDAR, S. K., BAKIR, A., KOCA, S., DINCBAS, F. O. (2016). Prostat kanseri Radyoterapisi Sırasında Fraksiyonlar Arası Seminal Vezikül Hareketleri ve Doz Değişimlerinin IGRT ile Değerlendirilmesi. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 26 - Sayı: 3, 129–135. https://ajindex.com/articles/322821

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Liauw SL, Weichselbaum RR, Rash C, et al. Biochemical control and toxicity after intensity-modulated radiation ther- apy for prostate cancer. Technol Cancer Res Treat 8: 201- 206, 2009.
  2. Cahlon O, Zelefsky MJ, Shippy A, et al. Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemi- cal outcomes. Int J Radiat Oncol Biol Phys 71: 330-337, 2008.
  3. De Meerleer G, Vakaet L, Meersschout S, et al. Intensity- modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients. Int J Radiat Oncol Biol Phys 60: 777-787, 2004.
  4. Michalski JM, Yan Y, Watkins-Bruner D, et al. Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high- dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial. Int J Radiat Oncol Biol Phys 87: 932- 938, 2013.
  5. Matzinger O, Duclos F, van den Bergh A, et al. Acute toxicity of curative radiotherapy for intermediate- and high-risk local- ized prostate cancer in the EORTC trial 22991. Eur J Cancer 45: 2825-2834, 2009.
  6. Kestin L, Goldstein N, Vicini F, et al. Treatment of prostate cancer with radiotherapy: should the entire seminal vesicle be included in the clinical target volume? Int J Radiat Oncol Biol Phys 54: 686-697, 2002.
  7. Bayman NA, Wylie JP. When should the seminal vesicles be included in the target volume in prostate radiotherapy? Clin Oncol (R Coll Radiol)19: 302-307, 2007.
  8. Kupelian PA, Langen KM, Willoughby TR, et al. Image-guided radiotherapy for localized prostate cancer: treating a moving target. Semin Radiat Oncol 8: 58-66, 2008.
  9. Mayyas E, Chetty IJ, Chetvertkov M, et al. Evaluation of multiple image-based modalities for image-guided radiation therapy (IGRT) of prostate carcinoma: a prospective study. Med Phys 40: (041707): 1-9, 2013.
  10. Crook JM, Raymond Y, Salhani D, et al. Prostate motion dur- ing standart radiotherapy as assessed by fiducial markers. Radiother Oncol 37: 35-42, 1995.
  11. Polat B, Guenther I, Wilbert J, et al. Intra-fractional uncer- tainties in image -guided intensity -modulated radiotherapy (IMRT) of prostate cancer. Strahlenther Oncol 184: 668-673, 2008.
  12. Aubry JF, Beaulieu L, Girouard LM, et al. Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imag- ing with radiopaque markers. Int J Radiat Oncol Biol Phys 60: 30-39, 2004.
  13. Bylund KC, Bayouth JE, Smith MC, et al. Analysis of intrafrac- t